Published in Proc Natl Acad Sci U S A on December 01, 1989
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J (1995) 3.16
Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst (2013) 3.07
Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol (1993) 2.77
Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med (1994) 2.71
The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res (2011) 2.60
Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys (2005) 2.29
Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J Clin Invest (1991) 2.08
Radiation as an immunological adjuvant: current evidence on dose and fractionation. Front Oncol (2012) 1.76
Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C. Mol Cell Biol (1991) 1.69
NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic Biol Med (2007) 1.58
Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci U S A (1990) 1.50
Radiation induced CNS toxicity--molecular and cellular mechanisms. Br J Cancer (2001) 1.44
In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer. Front Oncol (2012) 1.43
Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. J Exp Med (1992) 1.38
Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN. Proc Natl Acad Sci U S A (1991) 1.36
The tumor-immune microenvironment and response to radiation therapy. J Mammary Gland Biol Neoplasia (2010) 1.33
Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc Natl Acad Sci U S A (1993) 1.32
Transcriptional control of the TNF gene. Curr Dir Autoimmun (2010) 1.32
Cytokines in radiobiological responses: a review. Radiat Res (2012) 1.29
Molecular mechanisms and treatment of radiation-induced lung fibrosis. Curr Drug Targets (2013) 1.27
Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc Natl Acad Sci U S A (1992) 1.25
Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov (2013) 1.25
Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance. J Exp Med (1991) 1.23
Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. J Clin Oncol (2013) 1.22
Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation. Proc Natl Acad Sci U S A (1997) 1.20
Links between innate immunity and normal tissue radiobiology. Radiat Res (2010) 1.19
Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J Clin Invest (1991) 1.08
Genistein can mitigate the effect of radiation on rat lung tissue. Radiat Res (2010) 1.06
Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. J Virol (1994) 1.05
Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts. Proc Natl Acad Sci U S A (2001) 1.03
Combinations of immunotherapy and radiation in cancer therapy. Front Oncol (2014) 1.01
Suppression of rat cytomegalovirus replication by antibodies against gamma interferon. J Virol (1994) 0.97
Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy. J Thorac Dis (2014) 0.93
Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damage. Redox Biol (2014) 0.92
The impact of the myeloid response to radiation therapy. Clin Dev Immunol (2013) 0.92
Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis. Int J Exp Pathol (2001) 0.89
Exercise, sleep quality, and mediators of sleep in breast and prostate cancer patients receiving radiation therapy. Community Oncol (2010) 0.89
Changes in the ornithine cycle following ionising radiation cause a cytotoxic conditioning of the culture medium of H35 hepatoma cells. Br J Cancer (2003) 0.89
Radiation as immunomodulator: implications for dendritic cell-based immunotherapy. Radiat Res (2014) 0.87
Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer. Onco Targets Ther (2016) 0.86
Ionizing radiation enhances IL-6 and IL-8 production by human endothelial cells. Mediators Inflamm (1997) 0.86
SOD2-mediated adaptive responses induced by low-dose ionizing radiation via TNF signaling and amifostine. Free Radic Biol Med (2011) 0.85
Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment. Oncology (Williston Park) (2015) 0.85
Genetic and epigenetic features in radiation sensitivity Part I: cell signalling in radiation response. Eur J Nucl Med Mol Imaging (2005) 0.84
Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination. Cancer Immunol Immunother (2009) 0.84
Local irradiation of murine melanoma affects the development of tumour-specific immunity. Immunology (2009) 0.83
Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line. Clin Immunol (2013) 0.82
Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population. J Korean Med Sci (2012) 0.81
The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats. Inflammopharmacology (2009) 0.81
Irradiation up-regulates CD80 expression through induction of tumour necrosis factor-alpha and CD40 ligand expression on B lymphoma cells. Immunology (2002) 0.81
Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer (2016) 0.81
Chapter seven--Cancer treatment with gene therapy and radiation therapy. Adv Cancer Res (2012) 0.80
Targeting and utilizing primary tumors as live vaccines: changing strategies. Cell Mol Immunol (2011) 0.79
Oxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects. Cancer Lett (2013) 0.79
Molecular responses of radiation-induced liver damage in rats. Mol Med Rep (2014) 0.79
Clastogenic factors as potential biomarkers of increased superoxide production. Biomark Insights (2007) 0.79
Membrane-derived second messenger regulates x-ray-mediated tumor necrosis factor alpha gene induction. Proc Natl Acad Sci U S A (1994) 0.78
Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we? Eur Arch Otorhinolaryngol (2015) 0.78
Oral administration of melatonin modulates the expression of tumor necrosis factor-α (TNF-α) gene in irradiated rat cervical spinal cord. Rep Pract Oncol Radiother (2015) 0.77
Does ionizing radiation influence Alzheimer's disease risk? J Radiat Res (2012) 0.77
Immunomodulatory effects of radiation: what is next for cancer therapy? Future Oncol (2015) 0.77
Regulation of the release of tumour necrosis factor (TNF)alpha and soluble TNF receptor by gamma irradiation and interferon gamma in Ewing's sarcoma/peripheral primitive neuroectodermal tumour cells. J Cancer Res Clin Oncol (1997) 0.77
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response. J Transl Med (2014) 0.77
T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer. Oncotarget (2016) 0.77
SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2. Cancer Res (2016) 0.76
Linking the history of radiation biology to the hallmarks of cancer. Radiat Res (2014) 0.76
Biokinetics of nuclear fuel compounds and biological effects of nonuniform radiation. Environ Health Perspect (1995) 0.75
Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques. Clin Exp Immunol (2015) 0.75
Endogenous production of tumour necrosis factor is required for manganese superoxide dismutase expression by irradiation in the human monocytic cell line THP-1. Biochem J (1997) 0.75
Radiotherapy-Associated Long-term Modification of Expression of the Inflammatory Biomarker Genes ARG1, BCL2L1, and MYC. Front Immunol (2017) 0.75
The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications. Sci Immunol (2016) 0.75
Acute radiation dermatitis in breast cancer patients: challenges and solutions. Breast Cancer (Dove Med Press) (2017) 0.75
Early and late effects of radiation treatment for prevention of coronary restenosis: a critical appraisal. Heart (1999) 0.75
IPW-5371 Proves Effective as a Radiation Countermeasure by Mitigating Radiation-Induced Late Effects. Radiat Res (2016) 0.75
Silkworm hemolymph down-regulates the expression of endoplasmic reticulum chaperones under radiation-irradiation. Int J Mol Sci (2011) 0.75
Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol (2017) 0.75
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
The SOS regulatory system of Escherichia coli. Cell (1982) 16.90
A method for isolation of intact, translationally active ribonucleic acid. DNA (1983) 13.67
Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science (1989) 10.70
Tumor necrosis factor (TNF). Science (1985) 8.80
Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science (1985) 7.99
Molecular cloning of the complementary DNA for human tumor necrosis factor. Science (1985) 6.18
DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci U S A (1988) 4.30
Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science (1988) 3.60
Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys (1984) 2.47
Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest (1988) 2.29
UV-induced extracellular factor from human fibroblasts communicates the UV response to nonirradiated cells. Cell (1984) 1.80
Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology (1987) 1.61
Induction of beta-polymerase mRNA by DNA-damaging agents in Chinese hamster ovary cells. Mol Cell Biol (1989) 1.61
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc Natl Acad Sci U S A (1986) 1.51
Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res (1989) 1.46
X-ray sensitivity of fifty-three human diploid fibroblast cell strains from patients with characterized genetic disorders. Cancer Res (1980) 1.40
Induction of plasminogen activator by UV light in normal and xeroderma pigmentosum fibroblasts. Proc Natl Acad Sci U S A (1981) 1.37
Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factor. Cancer Res (1988) 1.31
Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor. Cancer Res (1989) 1.28
Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor. Immunology (1988) 1.17
Cytolysis by tumor necrosis factor is preceded by a rapid and specific dissolution of microfilaments. Proc Natl Acad Sci U S A (1989) 0.98
Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy. Int J Cancer (1988) 0.95
Letter: The involvement of indirect effects in cell-killing and DNA double-strand breakage in gamma-irradiated Escherichia coli K-12. Int J Radiat Biol Relat Stud Phys Chem Med (1976) 0.94
In vitro systems: standardization of endpoints. Int J Radiat Oncol Biol Phys (1979) 0.84
In vitro radiobiological parameters of human sarcoma cell lines. Int J Radiat Oncol Biol Phys (1988) 0.82
Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med (1988) 7.96
Head and neck cancer. N Engl J Med (1993) 6.33
Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res (1981) 5.08
Oligometastases. J Clin Oncol (1995) 4.95
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem (2000) 4.49
The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell (1982) 4.17
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res (1999) 4.17
Accurate three-dimensional registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr (1989) 3.12
Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology (1982) 2.55
Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature (1995) 2.54
Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation. Cancer Res (1983) 2.46
Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer. Int J Radiat Oncol Biol Phys (1995) 2.45
Xrcc3 is required for assembly of Rad51 complexes in vivo. J Biol Chem (1998) 2.44
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet (1995) 2.43
Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell (1980) 2.39
Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1990) 2.37
Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature (1998) 2.29
A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer. Clin Cancer Res (2000) 2.28
Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol (1992) 2.19
Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique. J Virol (1986) 2.15
Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants. Nature (1982) 2.11
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol (2003) 2.09
Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res (2000) 2.06
Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. J Infect Dis (1995) 2.05
Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery (1988) 1.98
BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II). Cancer Res (1998) 1.97
Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol (1986) 1.94
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol (1990) 1.90
Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism. Science (1983) 1.82
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res (1993) 1.80
Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. J Natl Cancer Inst (1988) 1.73
Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res (1980) 1.66
Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med (1982) 1.64
Spatial and temporal control of gene therapy using ionizing radiation. Nat Med (1995) 1.59
A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 1.59
Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma. J Exp Med (1989) 1.59
Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol (1995) 1.59
Correlation of cytotoxicity with incorporation of ara-C into DNA. J Biol Chem (1980) 1.58
Tumor necrosis factor expression in human epithelial tumor cell lines. J Clin Invest (1988) 1.53
Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest (1996) 1.52
The essential functions of human Rad51 are independent of ATP hydrolysis. Mol Cell Biol (1999) 1.51
Nasopharyngeal carcinoma. Lancet (1997) 1.51
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc Natl Acad Sci U S A (1986) 1.51
Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine. Hum Gene Ther (1998) 1.50
Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci U S A (1990) 1.50
Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J Clin Invest (1985) 1.49
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res (1996) 1.44
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol (1994) 1.44
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am (1999) 1.42
Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas. Cancer Res (1989) 1.41
X-ray sensitivity of fifty-three human diploid fibroblast cell strains from patients with characterized genetic disorders. Cancer Res (1980) 1.40
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. Cancer Invest (1995) 1.39
Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease. Int J Radiat Oncol Biol Phys (1995) 1.39
Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys (1994) 1.38
Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 (Dearing). J Virol (1986) 1.38
Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol (1988) 1.37
Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood (1997) 1.37
Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN. Proc Natl Acad Sci U S A (1991) 1.36
Role of mycobactin in the growth and virulence of tubercle bacilli. Infect Immun (1974) 1.34
Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc Natl Acad Sci U S A (1987) 1.34
Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. Cancer Res (1988) 1.34
The role of cdc2 in the expression of herpes simplex virus genes. Proc Natl Acad Sci U S A (2000) 1.34
Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells. J Biol Chem (1990) 1.32
Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc Natl Acad Sci U S A (1993) 1.32
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Ann Oncol (2010) 1.31
Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes. J Surg Oncol (1991) 1.29
Deficient recovery from potentially lethal radiation damage in ataxia telengiectasia and xeroderma pigmentosum. Nature (1978) 1.27
Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors. Gene Ther (1998) 1.26
Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc Natl Acad Sci U S A (1992) 1.25
Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen. J Clin Invest (2000) 1.25
Genetically engineered HSV in the treatment of glioma: a review. Rev Med Virol (2000) 1.24
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol (2000) 1.24
Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol (1997) 1.24
Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science (1989) 1.24
Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood (1996) 1.24
Iron release from corroded iron pipes in drinking water distribution systems: effect of dissolved oxygen. Water Res (2004) 1.22
Skin fibroblasts from a D-deletion type retinoblastoma patient are abnormally X-ray sensitive. Nature (1977) 1.21
Accumulation of specific RNAs encoding transcriptional factors and stress response proteins against a background of severe depletion of cellular RNAs in cells infected with herpes simplex virus 1. Proc Natl Acad Sci U S A (1999) 1.20
Topological analysis of the reovirus type 3 hemagglutinin. Virology (1983) 1.20
Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA. Proc Natl Acad Sci U S A (1981) 1.20
Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA. Cancer Res (1997) 1.19
Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes. J Clin Invest (1987) 1.18
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J Clin Oncol (1994) 1.18
Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res (1992) 1.16
cdc2 cyclin-dependent kinase binds and phosphorylates herpes simplex virus 1 U(L)42 DNA synthesis processivity factor. J Virol (2001) 1.15
Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis. J Biol Chem (1997) 1.15
Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol (2001) 1.15